BREAKING NEWS ~ Supreme Court says drug makers can ignore rival patents while researching generics News
BREAKING NEWS ~ Supreme Court says drug makers can ignore rival patents while researching generics

[JURIST] The US Supreme Court in a unanimous decision has ruled that drug companies can do "pre-clinical studies" under FDA rules on an existing patented drug in the process of developing a generic alternative to market in the future. Read a summary of Merck KGaA v. Integra Lifesciences [Duke Law backgrounder]. AP has more.

11:35 PM ET – The opinion is now available via Cornell LII.